Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: RADIATION: Radiotherapy|BIOLOGICAL: Anti-Thymocyte Globulin
Sponsor: European Institute of Oncology
Collaborators: Istituto Clinico Humanitas